Literature DB >> 19059704

Dickkopf-4 is frequently down-regulated and inhibits growth of colorectal cancer cells.

Sebastian Baehs1, Andreas Herbst, Susanne E Thieme, Claudia Perschl, Andrea Behrens, Silvio Scheel, Andreas Jung, Thomas Brabletz, Burkhard Göke, Helmut Blum, Frank T Kolligs.   

Abstract

Like Dickkopf-1 (DKK1), DKK4 is a target of beta-catenin/Tcf-4 in colorectal cancer. However, as a negative regulator of Wnt signalling its function in colorectal cancer cells is not well understood. We report that DKK4 is frequently down-regulated in colorectal cancer cell lines with deregulated beta-catenin/Tcf-4 and in primary colorectal cancers. Exposure of cancer cells to DKK4 strongly inhibits basal beta-catenin/Tcf-4 signalling activity, cancer cell growth and cell cycle progression. Therefore, loss of this negative feed-back loop provides Wnt factor expressing cancer cells with a growth advantage. Our data demonstrate that DKK4 is an important negative regulator of colon cancer cell growth.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19059704     DOI: 10.1016/j.canlet.2008.11.003

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  18 in total

Review 1.  Horizontal gene transfers with or without cell fusions in all categories of the living matter.

Authors:  Joseph G Sinkovics
Journal:  Adv Exp Med Biol       Date:  2011       Impact factor: 2.622

2.  DICKKOPF-4 activates the noncanonical c-Jun-NH2 kinase signaling pathway while inhibiting the Wnt-canonical pathway in human renal cell carcinoma.

Authors:  Hiroshi Hirata; Yuji Hinoda; Shahana Majid; Yi Chen; Mohd S Zaman; Koji Ueno; Koichi Nakajima; Z Laura Tabatabai; Nobuhisa Ishii; Rajvir Dahiya
Journal:  Cancer       Date:  2010-11-08       Impact factor: 6.860

Review 3.  Wnt modulators in the biotech pipeline.

Authors:  Jean-Philippe Rey; Debra L Ellies
Journal:  Dev Dyn       Date:  2010-01       Impact factor: 3.780

Review 4.  The role of Dickkopf family in cancers: from Bench to Bedside.

Authors:  You-Cheng Shao; Yan Wei; Jin-Fang Liu; Xiao-Yan Xu
Journal:  Am J Cancer Res       Date:  2017-09-01       Impact factor: 6.166

5.  Proteomic consequences of a single gene mutation in a colorectal cancer model.

Authors:  Patrick J Halvey; Bing Zhang; Robert J Coffey; Daniel C Liebler; Robbert J C Slebos
Journal:  J Proteome Res       Date:  2011-12-13       Impact factor: 4.466

6.  Identification, isolation and characterization of human LGR5-positive colon adenoma cells.

Authors:  Michael K Dame; Durga Attili; Shannon D McClintock; Priya H Dedhia; Peter Ouillette; Olaf Hardt; Alana M Chin; Xiang Xue; Julie Laliberte; Erica L Katz; Gina M Newsome; David R Hill; Alyssa J Miller; Yu-Hwai Tsai; David Agorku; Christopher H Altheim; Andreas Bosio; Becky Simon; Linda C Samuelson; Jay A Stoerker; Henry D Appelman; James Varani; Max S Wicha; Dean E Brenner; Yatrik M Shah; Jason R Spence; Justin A Colacino
Journal:  Development       Date:  2018-03-14       Impact factor: 6.862

7.  α-Ketoglutarate attenuates Wnt signaling and drives differentiation in colorectal cancer.

Authors:  Eric A Hanse; Amber N Habowski; Thai Q Tran; Haiqing Li; Mari B Ishak Gabra; Ying Yang; Xazmin H Lowman; Amelia M Ooi; Shu Y Liao; Robert A Edwards; Marian L Waterman; Mei Kong
Journal:  Nat Cancer       Date:  2020-03-20

8.  IWR-1 inhibits epithelial-mesenchymal transition of colorectal cancer cells through suppressing Wnt/β-catenin signaling as well as survivin expression.

Authors:  Sang Chul Lee; Ok-Hee Kim; Sang Kuon Lee; Say-June Kim
Journal:  Oncotarget       Date:  2015-09-29

9.  Comprehensive analysis of β-catenin target genes in colorectal carcinoma cell lines with deregulated Wnt/β-catenin signaling.

Authors:  Andreas Herbst; Vindi Jurinovic; Stefan Krebs; Susanne E Thieme; Helmut Blum; Burkhard Göke; Frank T Kolligs
Journal:  BMC Genomics       Date:  2014-01-28       Impact factor: 3.969

10.  Wnt secretion is required to maintain high levels of Wnt activity in colon cancer cells.

Authors:  Oksana Voloshanenko; Gerrit Erdmann; Taronish D Dubash; Iris Augustin; Marie Metzig; Giusi Moffa; Christian Hundsrucker; Grainne Kerr; Thomas Sandmann; Benedikt Anchang; Kubilay Demir; Christina Boehm; Svenja Leible; Claudia R Ball; Hanno Glimm; Rainer Spang; Michael Boutros
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.